Genenta Science SPA (Genenta Science SPA) FCF Yield % : -20.25 (As of Jun. 05, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Genenta Science SPA FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Genenta Science SPA's Trailing 12-Month Free Cash Flow is $-12.18 Mil, and Market Cap is $60.13 Mil. Therefore, Genenta Science SPA's FCF Yield % for today is -20.25%.

The historical rank and industry rank for Genenta Science SPA's FCF Yield % or its related term are showing as below:

GNTA' s FCF Yield % Range Over the Past 10 Years
Min: -30.38 Med: 0 Max: 0
Current: -20.25

GNTA's FCF Yield % is ranked worse than
58.6% of 1553 companies
in the Biotechnology industry
Industry Median: -14.22 vs GNTA: -20.25

Genenta Science SPA's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Genenta Science SPA FCF Yield % Historical Data

The historical data trend for Genenta Science SPA's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genenta Science SPA FCF Yield % Chart

Genenta Science SPA Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

-3.94

-7.87

-13.57

Genenta Science SPA Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial				-2.57	-4.25	-10.31	-15.32	-8.77

Competitive Comparison of Genenta Science SPA's FCF Yield %

For the Biotechnology subindustry, Genenta Science SPA's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genenta Science SPA's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genenta Science SPA's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Genenta Science SPA's FCF Yield % falls into.

Genenta Science SPA FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Genenta Science SPA's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-12.234	/	90.17415
	=	-13.57%

Genenta Science SPA's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-3.954	*	2	/	90.17415
	=	-8.77%

Genenta Science SPA FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Genenta Science SPA FCF Yield % Related Terms

Thank you for viewing the detailed overview of Genenta Science SPA's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Genenta Science SPA (Genenta Science SPA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (NAS:GNTA) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

K5F:Germany

Address

Via Olgettina No. 58, Milan, ITA, 20132

Website

https://www.genenta.com

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's lead product includes Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.